AURA BIOSCIENCES INC has a total of 32 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are IMCYSE SA, STRESSGEN BIOTECHNOLOGIES CORP and AVM BIOTECHNOLOGY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Japan | 2 | |
#9 | Hungary | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Syringes | |
#6 | Analysing materials | |
#7 | Electrotherapy | |
#8 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | De Los Pinos Elisabet | 26 |
#2 | Kines Rhonda C | 18 |
#3 | Macdougall John | 14 |
#4 | Schiller John T | 10 |
#5 | Schiller John Todd | 6 |
#6 | Rhonda C Kines | 5 |
#7 | Elisabet De Los Pinos | 5 |
#8 | Kines Rhonda | 4 |
#9 | Schiller John | 3 |
#10 | John Macdougall | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020198344A1 | Human papillomavirus nanoparticle formulations | |
CA3059882A1 | Targeted combination therapy | |
EP3517130A1 | Method of producing photosensitive molecules | |
US2014377170A1 | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells | |
WO2013067530A2 | Virion derived protein nanoparticles comprising radioisotopes for diagnosing, treating and monitoring malignant and systemic diseases | |
US2013012566A1 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia |